While the demand for APIs continues to grow, the manufacturing process is not without challenges. Cost pressures, stringent regulations, and the need for innovation frequently complicate production. The shift towards personalized medicine is pushing manufacturers to innovate rapidly, requiring them to develop APIs that cater to the unique needs of individual patients. Furthermore, supply chain disruptions, as witnessed during the COVID-19 pandemic, have highlighted vulnerabilities in procurement and logistics for raw materials, leading to increased focus on local sourcing and production capabilities.
api pharma manufacturing
Mitochondrial dysfunction is linked to various health issues, including metabolic disorders, cardiovascular diseases, and aging-related decline. Given PQQ’s role in enhancing mitochondrial function and its antioxidant properties, it is increasingly recognized as a candidate for dietary supplementation aimed at improving mitochondrial health. While the body can synthesize PQQ, dietary sources include fermented foods, green tea, and certain fruits and vegetables. Incorporating these into one’s diet may provide the necessary support for mitochondrial function and, by extension, overall cellular health.